<DOC>
	<DOC>NCT01358552</DOC>
	<brief_summary>This is an observational study in which patients who have been prescribed Néevo®/NéevoDHA® are invited to participate in surveys about their pregnancy and experiences with Néevo®/NéevoDHA®. The purpose of this study is to increase the understanding of the role of L-methylfolate among patients who are candidates for Néevo®/NéevoDHA®, provide patients with personalized education and support during their pregnancies, and contribute to the overall understanding of the needs and concerns of women facing intermediate- to high-risk pregnancies.</brief_summary>
	<brief_title>Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand &amp; Support)</brief_title>
	<detailed_description>Surveys used to conduct this study will be administered via telephone or online by InfoMedics, Inc., a company with a system for developing such patient-physician feedback programs. Participating physicians will ask their patients to participate in the program after Néevo®/NéevoDHA® has been prescribed and provide them with a patient brochure containing an introduction to the program and instructions on how to enroll. Patients interested in participating self-enroll, take a brief survey before starting their Néevo®/NéevoDHA® prescription, and then a follow-up survey 4 weeks after they have started taking Néevo®/NéevoDHA®. As patients complete surveys within the study, their physician will receive individualized feedback reports outlining their patient's treatment experience and progress. Patients will also receive a copy of their own reports, to help encourage them to continue taking Néevo®/NéevoDHA® as directed. Patients will also receive educational materials about diet and nutrition during pregnancy.</detailed_description>
	<criteria>New Néevo®/NéevoDHA® Start. Only for women who are pregnant and taking brand name Néevo®/ NéevoDHA® under a physicians care. Patients who are not pregnant. If participant indicates that she did not get a prescription for Néevo®/ NéevoDHA®, she will not be able to complete the survey(s). For the followup survey, if the participant indicates that she has not been taking Néevo®/NéevoDHA®, she will not be able to complete the survey( (s).</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Neevo</keyword>
	<keyword>Neevo DHA</keyword>
	<keyword>L-methylfolate</keyword>
	<keyword>anemia during pregnancy</keyword>
	<keyword>folic acid</keyword>
	<keyword>vitamin B12</keyword>
	<keyword>prenatal vitamins</keyword>
	<keyword>hemoglobin</keyword>
	<keyword>iron deficiency</keyword>
	<keyword>Pregnancy</keyword>
</DOC>